Department: DEPARTMENT OF JUSTICE
Pages: 1
[FR Doc 03-29236] 1. Chemical Registration Waivers; Exemption From Chemical Registration Fees for
DEA is proposing amending its regulations to waive the requirement of registration for contract processors, medical/first aid kit providers, distributors of sample packages of drug products, and distributors of research/reference standards pursuant to 21 U.S.C. 822(d). These actions are being taken in response to industry comments and suggestions.
Published: 2003-11-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 03-29336] 2. Recordkeeping and Reporting Requirements for Drug Products Containing
DEA proposes to amend its regulations to require additional
recordkeeping and reporting requirements for drug products containing
gammahydroxybutyric acid (GHB) for which an application has been
approved under the Federal Food, Drug, and Cosmetic Act. DEA proposes [[Page 66049]]
these changes pursuant to section 4 of the ``Hillory J. Farias and
Published: 2003-11-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration
[FR Doc 03-29358] 3. Agency Information Collection Activities: Proposed Collection; Comments
The Department of Justice (DOJ), Federal Bureau of Investigations (FBI) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and
Published: 2003-11-25 DEPARTMENT OF JUSTICE : Federal Bureau of Investigation
Pages: 1